Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
Clinical trial NCT04439955 · COMPLETED
Trial details
- NCT number
- NCT04439955
- Sponsor
- Stero Biotechs Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2021-07-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.